|
Definition: "An ergogenic aid is any substance or phenomenon that enhances performance "
|
|
||||||||
17.12.2012 |
|
|
HMB slows down muscle loss if you're not training
HMB may also be interesting for sick or elderly people who are losing muscle mass, for example through forced inactivity. Sarcopaenia researchers at West Virginia University tested this theory in an experiment involving old lab rats aged 34 months. The researchers disabled the hind foot of one group of animals for 14 days [HS], after which they let the rats use the leg for the following 14 days [R]. In a control group nothing was done to the animals' hind leg [CC].
The researchers measured the amount of strength the rats could develop with their hind leg before HS, after HS and after R. The figure below shows that inactivity weakened the muscles, but that HMB supplementation reduced the strength loss. The researchers used a dose of 340 mg HMB per kg bodyweight per day. The human equivalent of this dose would be 4-7 g HMB per day.
The figures below show what happened to the plantaris muscle. You can see that HMB supplementation reduced the decrease in muscle mass in the experimental group. Under the microscope the researchers saw more dead muscle cells [the apoptotic index was higher] in the muscles of the HS rats, but they also saw that HMB supplementation reduced muscle cell death. In the muscle cells of the HS rats, HMB inhibited the production of the suicide protein caspase-9.
![]() ![]()
"HMB should be further evaluated and considered as part of a potential therapeutic strategy along with more moderate muscle loading to prevent muscle loss in aging and perhaps other conditions of muscle wasting", the researchers write.
The study was funded by Abbott Laboratories, which manufactures, among other things, supplements and sports nutrition products. Abbot has a patent on the use of HMB in products "for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss". [United States Patent 8217077]
Source:
More:
|
|